{
  "id": 20015025,
  "updated": "2019-02-18T19:03:06Z",
  "additionalIndexing": "2841;08",
  "affairType": {
    "abbreviation": "Qst.",
    "id": 14,
    "name": "Heure des questions. Question"
  },
  "author": {
    "councillor": {
      "code": 2520,
      "gender": "m",
      "id": 497,
      "name": "Mugny Patrice",
      "officialDenomination": "Mugny Patrice"
    },
    "faction": {
      "abbreviation": "Groupe G",
      "id": 6,
      "name": "Groupe écologiste"
    },
    "type": "author"
  },
  "deposit": {
    "council": {
      "abbreviation": "CN",
      "id": 1,
      "name": "Conseil national",
      "type": "N"
    },
    "date": "2001-03-19T00:00:00Z",
    "legislativePeriod": 46,
    "session": "4606"
  },
  "descriptors": [
    {
      "key": "L06K010503010201",
      "name": "Generika",
      "type": 1
    },
    {
      "key": "L03K010503",
      "name": "pharmazeutische Industrie",
      "type": 1
    },
    {
      "key": "L04K03040215",
      "name": "Südafrika",
      "type": 1
    }
  ],
  "drafts": [
    {
      "consultation": {
        "resolutions": [

        ]
      },
      "federalCouncilProposal": {
      },
      "index": 0,
      "links": [

      ],
      "preConsultations": [

      ],
      "references": [

      ],
      "relatedDepartments": [
        {
          "abbreviation": "DEFR",
          "id": 8,
          "name": "Département de l'économie, de la formation et de la recherche",
          "leading": true
        }
      ],
      "states": [
        {
          "date": "/Date(984956400000+0100)/",
          "id": 27,
          "name": "Liquidé"
        }
      ],
      "texts": [

      ]
    }
  ],
  "handling": {
    "date": "2001-03-19T00:00:00Z",
    "legislativePeriod": 46,
    "session": "4606"
  },
  "language": "fr",
  "relatedAffairs": [

  ],
  "roles": [
    {
      "councillor": {
        "code": 2520,
        "gender": "m",
        "id": 497,
        "name": "Mugny Patrice",
        "officialDenomination": "Mugny Patrice"
      },
      "faction": {
        "abbreviation": "Groupe G",
        "id": 6,
        "name": "Groupe écologiste"
      },
      "type": "author"
    }
  ],
  "shortId": "01.5025",
  "state": {
    "id": 27,
    "name": "Liquidé",
    "doneKey": "1",
    "newKey": 0
  },
  "texts": [
    {
      "type": {
        "id": 5,
        "name": "Texte déposé"
      },
      "value": "<p>Plusieurs multinationales, dont trois grands groupes suisses (Novartis, Roche et Janssen-Cilag) se battent devant la justice sud-africaine pour empêcher ce pays d'importer ou de produire des médicaments génériques, notamment pour soigner le sida. Il s'agit clairement d'un combat des multinationales contre les populations pauvres. J'aimerais connaître la position du Conseil fédéral à ce propos.</p><p>N'a-t-il rien à dire aux multinationales suisses impliquées dans ce procès?</p>"
    },
    {
      "type": {
        "id": 1,
        "name": "Titre de l'objet"
      },
      "value": "Importation de médicaments génériques en Afrique du Sud. Procès"
    }
  ],
  "title": "Importation de médicaments génériques en Afrique du Sud. Procès"
}